Efficacy and safety of IL inhibitors, TNF-α inhibitors, and JAK inhibitors in patients with ankylosing spondylitis: a systematic review and Bayesian network meta-analysis

BACKGROUND: Biologics and Janus kinase (JAK) inhibitors are commonly used to improve ankylosing spondylitis (AS) symptoms if conventional treatments are ineffective or unsuitable. This systematic review aimed to compare the therapeutic effects and safety of JAK inhibitors, tumor necrosis factor-alph...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Cong, Shu, Jianlong, Shao, Wenhui, Zhou, Zhengxin, Guo, Huayang, Wang, Jingang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009571/
https://www.ncbi.nlm.nih.gov/pubmed/36923085
http://dx.doi.org/10.21037/atm-23-195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009571/
https://www.ncbi.nlm.nih.gov/pubmed/36923085
http://dx.doi.org/10.21037/atm-23-195

Ejemplares similares